Clinical Features and Outcomes of Advanced PNETs Treated with Sunitinib: Data from CRIPNET-GETNE Study

#1937

Introduction: There are several effective drugs for advanced pancreatic neuroendocrine tumors (PNETs) but the right treatment sequence hasn’t been defined yet.

Aim(s): To describe the clinical features and outcomes of the CRIPNET STUDY population, advanced PNETs treated with sunitinib.

Materials and methods: This is a multicentric study supported by Spanish multidisciplinary scientific society GETNE. Overall survival (OS) and progression-free survival (PFS) were compared with Kaplan-Meier and Cox analysis.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Solis-Hernandez M

Authors: Solis-Hernandez M, Calvo-Temprano D, Carmona-Bayonas A, García-Carbonero R, Custodio A,

Keywords: Sunitinib, targeted therapies,